These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20797576)

  • 1. Oxidative stress, renal anemia, and its therapies: is there a link?
    Căpuşă C; Mircescu G
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S71-6. PubMed ID: 20797576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
    Garneata L
    J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS; Wexler D; Iaina A
    J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron supplementation in the anaemia of renal and cardiac failure--a double-edged sword?
    Slotki I
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii16-23. PubMed ID: 16024827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing renal anaemia management--benefits of early referral and treatment.
    Stevens P
    Nephrol Dial Transplant; 2005 Sep; 20 Suppl 8():viii22-26. PubMed ID: 16079327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antioxidants, carnitine and erythropoietin].
    Calò LA; Bertipaglia L; Pagnin E
    G Ital Nefrol; 2006; 23 Suppl 34():S47-50. PubMed ID: 16633995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.
    Herrera J; Nava M; Romero F; Rodríguez-Iturbe B
    Am J Kidney Dis; 2001 Apr; 37(4):750-7. PubMed ID: 11273875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of anemia in chronic kidney disease: understandings in 2006.
    Levin A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):267-71. PubMed ID: 17420672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal anemia treatment and outcome of patients with chronic kidney disease].
    Kuragano T; Nakanishi T
    Nihon Jinzo Gakkai Shi; 2009; 51(7):852-6. PubMed ID: 19928557
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
    J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
    Vaziri ND
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):436-45. PubMed ID: 18542121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidative stress in uremia: the role of anemia correction.
    Lahera V; Goicoechea M; de Vinuesa SG; Oubiña P; Cachofeiro V; Gómez-Campderá F; Amann R; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S174-7. PubMed ID: 17130258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia, renal transplantation, and the anemia paradox.
    Rigatto C
    Semin Nephrol; 2006 Jul; 26(4):307-12. PubMed ID: 16949469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.